Showing results (241-250 of 821) with videos related to
Sort By:
Pageof 83
Lipids|August 19, 2007
A whole body, in vivo, fatty acid balance method to quantify PUFA metabolism (desaturation, elongation and beta-oxidation)Giovanni M Turchini, David S Francis, Sena S De SilvaJournal of Neuroscience Research|May 1, 1990
Multiple sclerosis and HLA class II susceptibility and resistance genesD G Haegert, M Michaud, C Schwab, et al.Nature Clinical Practice. Cardiovascular Medicine|June 26, 2007
Drug insight: aldosterone-receptor antagonists in heart failure--the journey continuesSrinivasa R Kalidindi, W H Wilson Tang, Gary S FrancisAnalytica Chimica Acta|May 29, 2007
Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detectionTeo Slezak, Paul S Francis, Nicole Anastos, et al.Microbes and Infection|January 16, 2007
Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cellsPetra J Edqvist, Margareta Aili, Junfa Liu, et al.Journal of Neurophysiology|February 19, 2010
Mapping human somatosensory cortex in individual subjects with 7T functional MRIR M Sanchez-Panchuelo, S Francis, R Bowtell, et al.Journal of Diarrhoeal Diseases Research|March 1, 1990
The zymodemes of Entamoeba histolytica in New Delhi, IndiaU K Baveja, S Francis, M Kaur, et al.Journal of Neuroscience Research|April 25, 2006
Novel role for aspartoacylase in regulation of BDNF and timing of postnatal oligodendrogenesisJeremy S Francis, Ana Olariu, Scott W McPhee, et al.Neurology|July 13, 2005
Interferon beta-1a in MS: results following development of neutralizing antibodies in PRISMSGordon S Francis, George P A Rice, Jonathan C Alsop, et al.The American Journal of Cardiology|January 19, 1995
Pathophysiologic aspects of end-stage heart failureG S Francis, K McDonald, C Chu, et al.Pageof 83